Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;21(2):303-310.
doi: 10.1038/s41436-018-0075-8. Epub 2018 Jul 16.

Clinical genome sequencing in an unbiased pediatric cohort

Isabelle Thiffault  1   2   3 , Emily Farrow  1   2   4 , Lee Zellmer  1   3 , Courtney Berrios  1   2 , Neil Miller  1 , Margaret Gibson  1 , Raymond Caylor  3 , Janda Jenkins  2   4 , Deb Faller  1 , Sarah Soden  1   2   4 , Carol Saunders  5   6   7
Affiliations

Clinical genome sequencing in an unbiased pediatric cohort

Isabelle Thiffault et al. Genet Med. 2019 Feb.

Abstract

Purpose: We report for the first time, the use of clinical genome sequencing (GS) in an unbiased pediatric cohort. We describe the clinical validation, patient metrics, ordering patterns, results, reimbursement, and physician retrieval of results for the first consecutive 80 cases.

Methods: Clinical GS was performed for both inpatients and outpatients undergoing etiologic evaluations. Results were reported in the electronic medical record. Evidence of report retrieval by clinicians and whether interpretation was concordant with laboratory report was obtained through retrospective chart review.

Results: Twenty definitive diagnoses were made in 19 patients (24%; n = 80). Except for two partial gene deletions, all diagnostic variants would have been detectable by our exome methods. Surprisingly, there was no documentation of communication of results to the family in the medical record for 17.5% of patients, and in 7.5%, physician and laboratory interpretations were discordant. Average insurance reimbursement was 30.2%, with yield for commercial payers significantly higher, at 54.1%.

Conclusions: The detection rate of GS is equivalent and potentially superior to exome sequencing (ES). Reimbursement rates were variable but overall satisfactory for commercial insurers, and poor for government entities. In addition, we identify opportunities for improvement in the communication of results to families, likely translatable to other tests and other institutions.

Keywords: Clinical validation; Diagnostics; Genome sequencing; Insurance reimbursement; Next-generation sequencing.

PubMed Disclaimer

References

    1. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6:265ra168. doi: 10.1126/scitranslmed.3010076. - DOI - PMC - PubMed
    1. Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4:154ra135. doi: 10.1126/scitranslmed.3004041. - DOI - PMC - PubMed
    1. Kohler S, Vasilevsky NA, Engelstad M, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865–D876. doi: 10.1093/nar/gkw1039. - DOI - PMC - PubMed
    1. Shen F, Wang L, Liu H. Phenotypic analysis of clinical narratives using Human Phenotype Ontology. Stud Health Technol Inform. 2017;245:581–5. - PMC - PubMed
    1. Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015;3:377–87. doi: 10.1016/S2213-2600(15)00139-3. - DOI - PMC - PubMed

Publication types